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The aim of this study was to evaluate the antimicrobial activity of aqueous extract of Psidium guineense Swartz (Arac ¸´ a-do-campo)
and ﬁve antimicrobials (ampicillin, amoxicillin/clavulanic acid, cefoxitin, ciproﬂoxacin, and meropenem) against twelve strains
of Staphylococcus aureus with a resistant phenotype previously determined by the disk diﬀusion method. Four S. aureus strains
showed resistance to all antimicrobial agents tested and were selected for the study of the interaction between aqueous extract
of P. guineense and antimicrobial agents, by the checkerboard method. The criteria used to evaluate the synergistic activity were
deﬁned by the fractional inhibitory concentration index (FICI). All S. aureus strains were susceptible to P. guineense as determined
by the microdilution method. The combination of the P. guineense extract with the antimicrobial agents resulted in an eight-fold
reduction in the MIC of these agents, which showed a FICI ranging from 0.125 to 0.5, suggesting a synergistic interaction against
methicillin-resistant Staphylococcus aureus (MRSA) strains. The combination of the aqueous extract of P. guineense with cefoxitin
showed the lowest FICI values. This study demonstrated that the aqueous extract of P. guineense combined with beta lactamics
antimicrobials, ﬂuoroquinolones, and carbapenems, acts synergistically by inhibiting MRSA strains.
1.Introduction
The widespread emergence of bacteria resistance to a large
numberofantimicrobialagentsposesmajorhealthproblems
because of diﬃculties in treatment [1]. Staphylococcus aureus
is an important pathogen both in community acquired and
nosocomial infections and a common etiological agent of
infections of many diﬀerent tissues and organs (e.g., furun-
cle, carbuncle, abscess, myocarditis, endocarditis, pneumo-
nia, meningitis, bacterial arthritis, and osteomyelitis) [2].
The multidrug resistant Staphylococcus aureus strains now
pose serious problems to hospitalized patients and their care
providers. The organism has successfully evolved numerous
strategies for resisting, the action to practically all antimicro-
bial agents [3]. Thus, it is extremely important to ﬁnd new
antimicrobial agents or new ways for the treatment of infec-
tious diseases caused by multidrug resistant microorganisms
[4].
The screening of plant extracts and phytochemicals for
antimicrobial activity has shown that higher plants, espe-
cially their secondary metabolites, are a source to provide
structurally diverse bioactive compounds with diﬀerent
pharmacological activities, including antimicrobials [5].
According to Hemaiswarya et al. [6], plants-derived anti-
microbials are less potent, which enhances the need to adopt
a synergistic interaction between its bioactive compounds2 The Scientiﬁc World Journal
to combat infections. Based on this knowledge, several
studies have been published using crude plant extracts or
phytochemicals combined with antimicrobial agents. These
combinations can enhance the eﬃcacy of the antimicrobial
agents and are an alternative to treat infections caused by
multidrug resistant microorganisms, which do not have any
eﬀective therapy available [4, 7, 8].
Psidium guineense Swartz (Myrtaceae), popularly known
as wild guava, is a shrub native and widely dispersed
throughout Tropical America. In Brazil, it mainly occurs
across the coastline [9, 10].
Fewstudieshavebeenfocusedonthephytochemicalpro-
ﬁle and pharmacological activity of this plant; however, it is
widely used in folk medicine in regions of South America
to treat infections of the gastrointestinal and genitourinary
tract [11]. These authors associated the presence of mainly
ﬂavonoids and tannins in the fruits and leaves of P. guineense
to be eﬀective against Streptococcus mutans strains.
The aim of the present study was to evaluate the antimi-
crobial activity of the aqueous extract of P. guineense and to
determinethesynergisticpotentialofthecombinationofthis
extract with ﬁve antimicrobial agents against MRSA strains.
2.MaterialsandMethods
2.1. Plant Material and Extract Preparation. The plant mate-
rials used in this study consisted of Psidium guineense Swartz
(leaves) that were collected in November/2009 from Moreno
city, Pernambuco, Brazil, (08◦07 07  S-35◦05 32  W). This
plant was identiﬁed by the biologist Olivia Cano, and the
voucher specimen was deposited in the Herbarium D´ ardano
deAndradeLima,InstitutoAgronˆ omicodePernambucoand
indexed under registration 83.564.
The leaves were air-dried for two weeks and then grinded
into ﬁne powder using an electric dry mill. A total of 50g
of the powder was soaked in 1000mL of boiled distilled
water and extracted exhaustively at room temperature for
48 hours. The extracts were ﬁltered through Whatman No.
2 ﬁlter paper. The aqueous extract was lyophilized to obtain
ad r yp o w d e re x t r a c t .
2.2. Phytochemical Screening. The preliminary phytochemi-
cal screening was carried out by various secondary metabo-
litespresentonaqueousextractofP.guineenseusingstandard
procedures[12–14].Thechromatographicanalysiswasmade
by TLC on Si gel (MERCK, Germany, 105553) devel-
oped by diﬀerent solvent systems: (EtOAc-HCOOH–AcOH-
H2O (100:11:11:26, v/v)) to investigate the presence of
saponins, ﬂavonoids, tannins, phenylpropanoids, alkaloids,
condensedproanthocyanidins,leucoanthocyanidins,andiri-
doids and (n-BuOH–Me2CO-buﬀer phosphate pH = 5.0
(40:50:10v/v)) to evaluate the presence of sugars.
2.3. Total Polyphenol Content (TPC). The total polyphe-
nol content (TPC) was determined colorimetrically by
using Folin-Ciocalteu’s reagent and expressed as pyrogallol,
according to the Brazilian Pharmacopoeia with modiﬁca-
tions [15]. Thus, samples of aqueous extract of P. guineense
(1000µg/mL) were prepared in distilled water. Concen-
trations (10 to 30µg/mL) were measured. The standard
pyrogallol (1000µg/mL) was prepared in distilled water. 80
microliters of each solution was transferred to a 25mL
ﬂaskcontainingdistilledwater(10mL)andFolin-Ciocalteu’s
reagent (1mL). The volume was completed with anhy-
drous sodium carbonate solution (10.75% w/v), resulting in
ﬁnal concentrations of 3.2µg/mL of pyrogallol. A standard
curve was determined with concentrations between 1.6 and
4.8µg/mL (r2 = 0.999). Final results were given as pyro-
gallol equivalents. The samples were scanned in a UV/VIS
spectrophotometer (Evolution 60S, Thermo Scientiﬁc), and
measurements were obtained 15min after addition of the
sodium-carbonate solution and scanning ranging from 500
to 900nm wavelength. Distilled water was used as a blank.
All measurements were performed in triplicate.
2.4. Bacterial Strains and Inoculum Standardization. S.
aureus strains (n = 11) were isolated from clinical specimens
and food. The standard strain used was S. aureus ATCC
25923. Strains were isolated in sheep blood agar and after
identiﬁcation they were stored in brain heart infusion (BHI)
plus glycerol 20% v/v [16]. The S. aureus strains used in
this study showed a resistant phenotype, by the diﬀusion
method,toseveralantimicrobialagentssuchasbeta-lactams,
aminoglycosides, macrolides, ﬂuoroquinolones, tetracycline,
chloramphenicol, and lincosamides. These strains were
cultured onto Mueller Hinton Agar (MHA) (Acumedia
Manufacturers, Baltimore, USA) and incubated at 37◦Cf o r
18 hours. Single colonies were selected and inoculated into
Mueller-Hintonbroth(AcumediaManufacturers,Baltimore,
USA) to turbidity comparable to that of 0.5 McFarland
standard, which is equivalent to a bacterial count of approx-
imately 108 CFU/mL.
After that, the bacterial suspension was diluted in saline
(1:10) to obtain a ﬁnal inoculum of 107 CFU/mL.
2.5. Antimicrobial Agents. The standard reference powders
of ampicillin; amoxicillin/clavulanic acid; cefoxitin; cipro-
ﬂoxacin; gentamicin; meropenem were provided by Euro-
farma Laborat´ orio LTDA, Brazil. Resistance was deﬁned
for each case: ampicillin (AMP, MIC ≥ 0.25µg/mL);
amoxicillin/clavulanic acid (AMC, MIC ≥ 8µg/mL); cefox-
itin (CFO, MIC ≥ 4µg/mL); ciproﬂoxacin (CIP, MIC ≥
4µg/mL); gentamicin (GEN, MIC ≥ 8µg/mL; meropenem
(MER, MIC ≥ 16µg/mL).
2.6. Antimicrobial Activity. The Minimal Inhibitory Con-
centration (MIC) test was performed by the microdilution
broth method, following the recommendations established
by Clinical Laboratory Standards Institute, [17], with some
modiﬁcations. Serial two-fold dilutions of aqueous extract
of P. guineense and antimicrobial agents were prepared
in sterile 96-well microplates containing Mueller Hinton
broth (MHB). Five microliters of bacterial suspension were
inoculated in each well to give a ﬁnal concentration of
104 CFU/mL. P. guineense extract and antimicrobial agents
concentrations ranged from 7.25 to 1000µg/mL and 3.12 toThe Scientiﬁc World Journal 3
400µg/mL, respectively. The growth inhibition was demon-
stratedbyopticaldensityat630nmusingamicroplatereader
(Thermo plate—TP Reader). Considering the total growth
(100%) in the control well (MHB + bacteria), the percentage
of growth reduction was attributed to the remaining wells.
The MIC was reported as the lowest concentration of P.
guineense extract or antimicrobial agents that inhibited the
bacterial growth after 24h of incubation at 37◦C. In order to
determine the Minimal Bactericidal Concentration (MBC),
the contents of the well that showed higher or equal than
70% of growth inhibition were seeded into MHA. After 24h
of incubation at 37◦C, the number of surviving S. aureus
was determined. The MBC was deﬁned as the lowest extract
concentration at which 99.9% of the bacteria have been
killed. All experiments were carried out in duplicate on two
diﬀerent days.
2.7. Determination of In Vitro Synergistic Activity. Com-
binations of P. guineense and antimicrobial agents were
tested by the checkerboard method. The appropriate dilu-
tion of P. guineense extract and antimicrobial agents were
performed into MHB. From these dilutions, one hundred
microliters were added in 96-well microplates to obtain a
ﬁnal concentration equal to MIC or six dilutions lower
than MIC to P. guineense and nine dilutions lower than
MIC to antimicrobial agents. Each well received 5µL of the
bacterial suspensions (107 CFU/mL). Plates were incubated
for 24 hours. Interpretation of the data was achieved by
calculating the fractional inhibitory concentration index
(FICI) as follows: (MIC of P. guineense in combination
with antimicrobial agents/MIC of P. guineense) + (MIC of
antimicrobial agents in combination with P. guineense/MIC
of antimicrobial agents). The combination was considered to
be synergistic when the FICI was ≤0.5, additive when it was
0.5 to ≤1, and antagonistic when ≥2[ 18].
3. Results
3.1. Phytochemical Proﬁle. The phytochemical proﬁle from
thePsidiumguineenseextractshowedthepresenceoftannins,
ﬂavonoids, condensed proanthocyanidins, leucoanthocyani-
dins, and sugar. On the other hand, the presence of alkaloids,
phenylpropanoid, and saponins was not veriﬁed. The aque-
ous extract of P. guineense yielded 3.7% (w/w) over 50g of
plant material.
Concerning the total polyphenol content, the results of
this study suggest that the aqueous extract of P. guineensis
show an important amount of such secondary metabolites.
Thus, the total polyphenol content was 21.62 ± 0.40g%
(1.51%) as pyrogallol equivalent.
3.2. Antimicrobial Activity. MIC and MBC values of P. guin-
eense extract and of the ampicillin, amoxicillin/clavulanic
acid, cefoxitin, ciproﬂoxacin, gentamicin, and meropenem
against twelve S. aureus strains are shown in Table 1.
The aqueous extract of P. guineense showed a strong
activity against all S. aureus strains with MIC values between
250and500µg/mL.TheS.aureusstrainsrevealedaresistance
proﬁle against most antimicrobial agents tested, in particular
to the beta-lactam antibiotics. The MIC values for ampicillin
and cefoxitin ranged from 3.12 to 400µg/mL which showed
to be less eﬀective against the S. aureus strains tested. For
amoxicillin/clavulanic acid, the values ranged from 3.12 to
50µg/mL. Among all S. aureus strains tested, seven showed
to be resistant to ciproﬂoxacin. For meropenem, MIC values
ranged from 3.12 to 25µg/mL. All strains showed to be
sensitive to gentamicin, except LFBM 26, LFBM 28, LFBM
33. Four strains of S. aureus (LFBM 01, LFBM 26, LFBM
28, LFBM 33) showed resistance to all antimicrobial agents
tested.Thisresistanceproﬁleselectedthemicroorganismsfor
the study of the interaction between P. guineense extract and
antimicrobial agents. The values of MBC were higher than
MIC in one dilution.
3.3. Determination of In Vitro Synergistic Activity. The MICs
obtained by the combination of the aqueous extract of
P. guineense with ampicillin, amoxicillin/clavulanic acid,
cefoxitin, ciproﬂoxacin, and meropenem, against S. aureus
strains (LFBM 01, LFBM 26, LFBM 28, LFBM 33) are
listed in Table 2. The minimal inhibitory concentrations of
P. guineense extract (250µg/mL) enhanced the antistaphy-
lococcal activity of all antimicrobial agents. The synergistic
activity was detected by an eight-fold decrease in the MIC of
the antimicrobial agents in the combination and determined
by the FICI ≤0.5.
The combination of the aqueous extract of P. guineense
and cefoxitin showed the lowest FICI whose values ranged
from 0.125 to 0.5. The MIC of cefoxitin (individual MIC
100–400µg / m L )w a sl o w e r e dt o1 / 5 1 2( c o m b i n e dM I C
ranged 0.19–0.78µg/mL), when it was used in combination
with the aqueous extract of P. guineense (MIC 250µg/mL).
For S. aureus LFBM 26 and LFBM 33 strains, this com-
bination was also eﬃc i e n to nr e d u c i n gt h eM I Co fP.
guineense extract to 1/8 × MIC (31.25µg/mL) or 1/4 × MIC
(62.25µg/mL), respectively.
Theinhibition ofthegrowthofalltheS.aureusstrainsby
meropenem was enhanced by P. guineense extract (FICI 0.5).
This combination was more eﬀective against LFBM 28 (FICI
0.25) which individual MIC of P. guineense (250µg/mL)
lowered to 1/4 × MIC.
For S. aureus LFBM 33 strain, the MIC value of ci-
proﬂoxacin (individual MIC 50µg/mL) was lowered to
0.78µg/mL when combined with P. guineense extract (1/4
× MIC) enhancing the antistaphylococcal activity of this
ﬂuoroquinolone (FICI 0.25). All other combinations of the
aqueous extract of P. guineense with antimicrobial agents
demonstrated synergistic activity, enhancing its activity, with
FICI 0.5.
4. Discussion
Phytochemicals have great potential as antimicrobial com-
pounds and have been proven to have great therapeutic
potential [19]. Some secondary metabolites have the ability
to increase the susceptibility of the microorganism. When
used in combination, these metabolites have the potential
to either inhibit the modiﬁed targets or exhibit a synergy by4 The Scientiﬁc World Journal
Table 1: MIC/MBC of the aqueous extract of Psidium guineense and antimicrobial agents against MRSA strains.
Staphylococcus
aureus
MIC/MBC (µg/mL)
AMC AMP CEF CIP GET MER AE Resistance phenotype1
ATCC 25923 3.12/6.24 3.12/6.24 3.12/6.24 3.12/6.24 0.39/0.78 3.12/6.24 250/500 Control strain
LFBM 01 25.0/50.0 400/800 400/800 50.0/100 12.5/25.0 25.0/50.0 250/500 AMC, CFO, CIP, GET
LFBM 05 6.25/12.5 100/200 25/50.0 3.12/6.24 3.12/6.24 12.5/25.0 250/500 AMP, AZI, CFO, PEN
LFBM 08 3.12/6.24 100/200 12.5/25.0 3.12/6.24 3.12/6.24 6.25/12.5 250/500 AMP; AZI, CIP, CFO
LFBM 16 12.5/25.0 25.0/50.0 12.5/25.0 3.12/6.24 3.12/6.24 6.25/12.5 250/500 AMP, AZI, CFO, PEN
LFBM 26 50.0/100 400/800 400/800 50.0/100 25.0/50.0 25.0/50.0 250/500 AMC, AMP, CFO, CIP
LFBM 28 25.0/50.0 400/800 100/200 50.0/100 25.0/50.0 12.5/25.0 250/500 AMC, CIP, CFO, GET
LFBM 29 12.5/25.0 50.0/100 25/50.0 3.12/6.24 3.12/6.24 12.5/25.0 500/1000 AMC, AMP, CFO, PEN
LFBM 30 12.5/25.0 200/400 12.5/25.0 50.0/100 3.12/6.24 12.5/25.0 250/500 AMC, AMP, CFO, CIP
LFBM 31 12.5/25.0 100/100 12.5/25.0 50.0/100 3.12/6.24 6.25/12.5 250/500 AMP, AZI, CFO; CIP;
LFBM 32 12.5/25.0 200/200 12.5/25.0 50.0/100 3.12/6.24 12.5/25.0 250/500 AMP, CFO, CIP, PEN
LFBM 33 12.5/25.0 200/200 200/200 50.0/100 3.12/6.24 12.5/25.0 250/500 AMC, AMP, CFO, CIP
MIC: minimal inhibitory concentration; MBC: minimal bactericidal concentration; ATCC: American Type Culture Collection; LFBM: Laborat´ orio de
Fisiologia e Bioqu´ ımica de Microorganismos; AMC: amoxicillin/clavulanic acid; AMP: ampicillin; AZI: azithromycin; CFO: cefoxitin; CIP: ciproﬂoxacin;
GET: gentamicin; PEN: penicillin; MER: meropenem; AE: aqueous extract of P. guineense.
1Resistance phenotype determined by the disk-diﬀusion method.
Table 2: Combination testing of the aqueous extract of Psidium guineense with antimicrobial agents against MRSA strains.
Staphylococcus
aureus Combination Individual
MIC (µg/mL)
Combination
MIC (µg/mL)
Individual
FIC
FIC index
(FICI) Interpretation % MIC
reduced
%r e d u c t i o n
of viable
cells1
LFBM 01
AE + AMC 250/25 125/0.048 0.5/0.002 0.5 Synergistic 50.0/99.8 80.21
AE + AMP 250/400 125/0.78 0,5/0.002 0.5 Synergistic 50.0/99.8 84.43
AE + CFO 250/400 125/0.78 0.5/0.002 0.5 Synergistic 50.0/99.8 87.04
AE + CIP 250/50 125/0.09 0.5/0.002 0.5 Synergistic 50.0/99.8 93.49
AE + MER 250/25 125/0.048 0.5/0.002 0.5 Synergistic 50.0/99.8 84.24
LFBM 26
AE + AMC 250/50.0 125/0.78 0.5/0.002 0.5 Synergistic 50.0/99.8 88.82
AE + AMP 250/400 125/0.78 0.5/0.002 0.5 Synergistic 50.0/99.8 83.58
AE + CFO 250/400 31.25/0.78 0.125/0.002 0.125 Synergistic 87.5/99.8 80.90
AE + CIP 250/50.0 125/0.09 0.5/0.002 0.5 Synergistic 50.0/99.8 94.59
AE + MER 250/25 125/0.048 0.5/0.002 0.5 Synergistic 50.0/99.8 80.76
LFBM 28
AE + AMC 250/12.5 125/0.024 0.5/0.002 0.5 Synergistic 50.0/99.8 83.38
AE + AMP 250/400 125/0.78 0.5/0.002 0.5 Synergistic 50.0/99.8 89.71
AE + CFO 250/100 125/0.19 0.5/0.002 0.5 Synergistic 50.0/99.8 86.91
AE + CIP 250/50.0 125/0.09 0.5/0.002 0.5 Synergistic 50.0/99.8 94.45
AE + MER 250/25.0 62.5/0.048 0.25/0.002 0.25 Synergistic 75.0/99.8 89.08
LFBM 33
AE + AMC 250/12.5 125/0.024 0.5/0.002 0.5 Synergistic 50.0/99.8 78.89
AE + AMP 250/200 125/0.39 0.5/0.002 0.5 Synergistic 50.0/99.8 76.72
AE + CFO 250/200 62.5/0.39 0.25/0.002 0.25 Synergistic 75.0/99.8 81.53
AE + CIP 250/50.0 62.5/0.78 0.25/0.002 0.25 Synergistic 75.0/99.8 94.09
AE + MER 250/12.5 125/0.024 0.5/0.002 0.5 Synergistic 50.0/99.8 81.84
MIC: minimal inhibitory concentration; FIC: fractional inhibitory concentration; AMC: amoxicillin/clavulanic acid; AMP: ampicillin; CFO: cefoxitin; CIP:
ciproﬂoxacin; MER: meropenem; AE: aqueous extract of P. guineense; LFBM: Laborat´ orio de Fisiologia e Bioqu´ ımica de Microorganismos.
%o fM I Cr e d u c e d= (MICalone −MICcombined) ×100/MICalone.
1%reduction of viable cells in wells containing the combination aqueous extract of P. guineense (1/2 MIC) and antimicrobials agents (1/512 MIC).The Scientiﬁc World Journal 5
blockingoneormoreofthetargetsinthemetabolicpathway,
acting as a modiﬁer of multidrug resistance mechanisms [6].
Severalstudieshaveinvestigatedtheinteractionsbetween
antibiotics and phytochemicals or crude extracts against
MRSA strains [4, 7, 8, 20].
In the Myrtaceae family, there is a large variety of phyto-
chemicals with antimicrobial activity which include terpenes
present in essential oils, ﬂavonoids [21], and tannins [22].
The genus Psidium is native to America but is distributed
worldwide.Theirspecimensaretraditionallyusedinthepre-
vention or treatment of a large number of diseases. Prepara-
tionsoftwigsorleavesofPsidiumspeciesareextensivelyused
forthecontrolofgastrointestinalandrespiratorydisordersas
well as in the treatment of skin damage [23].
Ethnopharmacological evaluation demonstrated the an-
timicrobial activities of Psidium ssp. that explain its use
for the treatment of infectious diseases of the digestive,
respiratory, urinary tract as well as the skin and soft tissues.
Within this genus, P. guajava is the most studied and used
species [24]. Thus, we are interested in P. guineense,a n
indigenous plant of Brazil, because it is characterized by its
ample spectrum of uses including gastrointestinal disorders,
infection of the genitourinary tract, treatment of colds,
bronchitis, and ulcers [25].
According to Sartoratto et al. [26], strong activity is for
MIC values between 50–500µg/mL, moderate activity MIC
values between 600–1500µg/mL, and weak activity above
1500µg/mL. Comparing with literature results, the aqueous
extract of P. guineense (250–500µg/mL) has a strong activity
against MRSA strains tested.
The phytochemical analysis from the leaves of P. guin-
eense indicated the presence of ﬂavonoids, hydrolysable, and
condensed tannins distributed throughout the leaf tissue
[27]. These results are in agreement with those obtained in
the present study. Total polyphenol content 21.62 ± 0.40g%
determined in aqueous extract of Psidium guineense plays an
important role on biological properties of this extract.
Neira Gonz´ alez et al. [11] associated the presence of
ﬂavonoids,mainlyavicularin,quercetin,andguaijaverinpre-
sent in the ethanolic extract of P. guineense, with the activity
against clinical isolated Streptococcus mutans strains.
Flavonoids have the ability to complex with proteins
and bacterial cells forming irreversible complexes mainly
with nucleophilic amino acids. This complex often leads to
inactivation of the protein and loss of its function [27].
Tannins are not crystallizable substances and when they
are in the aqueous system, form colloidal solutions. The
antimicrobial activity of tannins can be summarized as
follows: (i) binding with proteins and adhesins, inhibiting
enzymes, (ii) complexation with the cell wall and metal ions,
and (iii) disruption of the plasmatic membrane [28].
Synergism of natural products and antimicrobial agents
is a thrust area of phytomedicinal research, developing
novelperspectiveofphytopharmaceuticals.Thesynergismof
plant-derived compounds and antimicrobial agents has been
evaluated previously against pathogenic microorganisms.
The approach is not exclusive for extract combinations,
sinceeﬀectivecombinationsbetweensinglenaturalproducts,
essential oils or extracts with chemosynthetics or antibiotics
have been described [6, 29].
In addition to achieving these synergistic eﬀects, the
combinations of two or more compounds are essential for
the following reasons: (1) to prevent or suppress the emer-
gence of resistant strains, (2) to decrease dose-related toxic-
ity, as a result dosage, and (3) to attain a broad spectrum of
activity [18].
In this study, a growth inhibitory eﬀect of P. guineense
extract on MRSA strains was observed for its combinations
with beta-lactams, carbapenems, and ﬂuoroquinolones.
The combination of P. guineense extract and beta-lactam
may help to reduce the amount of antimicrobial agents used
and deliver a medicine with similar or greater potency as
antimicrobial. More importantly, since phytochemicals are
structurally diﬀerent from antimicrobial agents and often
have diﬀerent modes of action, they may provide new
means of studying the mechanisms of bacterial control at a
molecular level. With the increase prevalence of multidrug
resistant S. aureus, synergism testing using various combina-
tions of phytochemicals with antimicrobial agents could be a
powerful tool in helping to select appropriate antimicrobial
therapy [6, 29].
The indiscriminate use of antimicrobial agents in the
treatment of bacterial infections has led to the emergence
and spread of resistant strains, and it resulted in a great
loss of clinical eﬃcacy of previously eﬀective ﬁrst-line
antimicrobials which results in shifting of antimicrobial
treatment regimen to second-line or third-line antimicrobial
agents that are often more expensive with many side eﬀects
[30].Infact,studieshaveshowedthatcrudeextractsofplants
possess the ability to enhance the activity of antimicrobial
agents [4, 7, 8].
There is a wide list of phytochemicals which act as in-
hibitors, and a few of them are glycosylated ﬂavones sup-
pressing topoisomerase IV activity, myricetin inhibiting
DnaB helicase, allicin inhibiting RNA synthesis. Corilagin,
a polyphenol from Arctostaphylos uva-ursi is found to
markedly reduce the MIC of beta-lactam agents against
MRSA. According to Hemaiswarya et al. [6], there are two
possibilities regarding the mechanism of action of corilagin,
namely, inhibition of penicillin binding protein (PBP2a)
activity or inhibiting its production.
The polyphenol epigallocatechin gallate (EGCg) from
green tea is believed to be synergic with beta-lactam agents
since both attacked the same target site, namely, peptidogly-
can. EGCg inhibits the penicillinase produced by S. aureus
thereby restoring the activity of penicillin. The combination
of EGCg with ampicillin/sulbactam reduced the MIC90 to
4µg/mL from its initial value of 16µg/mL [6].
Hatano et al. [31] investigated the synergistic activity
of two proanthocyanidins isolated from the fruits of the
Zizyphus genus. Although the MICs of these polyphones
were 512–1024µg/moL, both reduced the MIC for oxacillin
to 1/2–1/16 of those in the absence of the polyphenols.
It is interesting to note that most plant secondary me-
tabolites have weak antimicrobial activity, several orders of
magnitudes less than that of common antimicrobial agents6 The Scientiﬁc World Journal
producedbybacteriaandfungi.Inspiteofthefactthatplant-
derived antimicrobials are less potent, plants ﬁght infections
successfully. Hence, is becomes apparent that plants adopts a
synergistic mechanism between their compounds [29].
According to Rosales-Reyes et al. [32], the use of the
crude extract in our study was intentional and based on the
belief that it would be the closest representation to that of
traditional preparations.
Therefore, it is speculated that the eﬃcacy of a crude
extract may be due to the interplay between the diﬀerent
active constituents that may be present in the extract leading
tobetteractivityand/ordecreaseinpotentialtoxicityofsome
individual constituents [33].
5. Conclusion
AnantibacterialeﬀectofP.guineenseextractandasynergistic
eﬀect in combination with antimicrobial agents were repro-
ducibly observed and might be an interesting alternative
therapy for infectious diseases caused by MRSA strains. In
addition, more studies, including toxicity tested in vivo, need
to be conducted on this plant before therapeutic treatments
are implemented.
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